Core Viewpoint - 德琪医药-B (06996.HK) has announced a share buyback plan, indicating confidence in its business outlook and aiming to create value for shareholders [1] Summary by Sections Share Buyback Plan - The board has approved a proposal to repurchase shares under the buyback authorization, with a maximum total price of HKD 40 million [1] - The company will fund the proposed share buyback using its internal resources [1] Financial Confidence - The board believes that the share buyback reflects the company's confidence in its business prospects and will ultimately benefit the company and its shareholders [1] - The company’s current financial resources are deemed sufficient to implement the proposed share buyback while maintaining a robust financial position [1]
德琪医药-B(06996.HK)：拟回购不超4000万港元公司股份